Live Breaking News & Updates on 022 Prnewswire New Research In The September 2022 Issue Of Jnccn Journal National Comprehensive Cancer Networkfinds Use Positron Emission Tomography Pet With 18 Fluorodeoxyglucose Fdg Tracer Adds Significant Prognostic Benefit Objectively Assessing Neoadjuvant Chemotherapy Response Borderline Resectable Locally Advanced Pancreatic Patients Prior To Surgery Quot We Were Astonished By How Metabolic Imaging Can Now Predict Outcomes High Accuracy Before Any Surgical Intervention

According to Mayo Clinic Comprehensive Cancer Center researchers, metabolic imaging (FDG-PET) in combination with traditional treatment response assessment methods can provide clinicians with critical information they need to guide therapy for pancreatic cancer patients. Increasingly impactful nature of research in JNCCN reflected in new high for the journal's Impact Factor, now 12.693. PLYMOUTH MEETING, Pa., Sept. 9, 2022 /PRNewswire/ New research in the September 2022 issue of JNCCN-Journal of the National Comprehensive Cancer Networkfinds the use of positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) tracer adds significant prognostic benefit in objectively assessing neoadjuvant chemotherapy response in borderline resectable/locally advanced pancreatic cancer patients prior to surgery. "We were astonished by how metabolic imaging can now predict outcomes with high accuracy before any surgical intervention," said senior research Mark J. Truty, MD, MS, ....

United States , Mahmoudm Al Hawary , Amrom Abdelrahman , Ajith Goenka , Facebook Nccnorg , Instagram Nccnorg , Panel For Pancreatic Adenocarcinoma , University Of Michigan Rogel Cancer Center , National Comprehensive Cancer Network , Mayo Clinic Comprehensive Cancer Center , Impact Factor , Mayo Clinic Comprehensive Cancer , Michigan Rogel Cancer Center , Pancreatic Adenocarcinoma , Neoadjuvant Therapy Response , Locally Advanced Pancreatic , National Comprehensive Cancer , Practice Guidelines , According To Mayo Clinic Comprehensive Cancer Center Researchers , Etabolic Imaging Fdg Pet In Combination With Traditional Treatment Response Assessment Methods Can Provide Clinicians Critical Information They Need To Guide Therapy For Pancreatic Cancer Patients Increasingly Impactful Nature Of Research Jnccn Reflected New High The Journal 39s Impact Factor , Ow 12 693 Plymouth Meeting , Sept 9 , 022 Prnewswire New Research In The September 2022 Issue Of Jnccn Journal National Comprehensive Cancer Networkfinds Use Positron Emission Tomography Pet With 18 Fluorodeoxyglucose Fdg Tracer Adds Significant Prognostic Benefit Objectively Assessing Neoadjuvant Chemotherapy Response Borderline Resectable Locally Advanced Pancreatic Patients Prior To Surgery Quot We Were Astonished By How Metabolic Imaging Can Now Predict Outcomes High Accuracy Before Any Surgical Intervention , Uot Said Senior Research Markj Truty , Ayo Clinic Comprehensive Cancer Center Quot Not Only That , Ut Fdg Pet Response Was The Single Largest Preoperative Predictor Of Survival For These Patients Decisively Identified More Than 85 Suspected To Have Major Pathological Responses This Isa Very Impressive Proportion And Better Currently Available Biochemical Assessment Through Ca 19 9 Levels Alone ,